Indeed, the genistein and daidzein effects that are observed on breast cancer metastasis could rely on their agonist effect on ERα, which is consistent with the reported proliferative function of such compounds through the activation of this ER subtype [118,121]. This evidence concerns the gene ESR1 and breast carcinoma.